AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹31,724 Cr | ₹29,002 Cr | ₹24,855 Cr | ₹23,455 Cr | ₹24,775 Cr |
What is the latest Revenue of AUROBINDO PHARMA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹31,724 Cr |
| Mar2024 | ₹29,002 Cr |
| Mar2023 | ₹24,855 Cr |
| Mar2022 | ₹23,455 Cr |
| Mar2021 | ₹24,775 Cr |
How is Revenue of AUROBINDO PHARMA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹31,724 Cr | 9.39 | |
| Mar2024 | ₹29,002 Cr | 16.68 | |
| Mar2023 | ₹24,855 Cr | 5.97 | |
| Mar2022 | ₹23,455 Cr | -5.32 | |
| Mar2021 | ₹24,775 Cr | - | |
Compare Revenue of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹88,269.2 Cr | -1% | 7.9% | 37.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -1% |
7.9% |
37.1% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses